Cencora (COR) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($2.3M), but sales were much larger ($13.5M) over the same 12 months.
Past insider buys here: 3 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Lazarus Krikorian, Svp & Chief Accounting Officer sold 986 shares at $330.96 ($326K).
- Trade date
- Nov 2, 2026
- Disclosed to the SEC
- Nov 3, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All COR insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
COR insider transactions (Form 4)
Open-market purchases and sales. 118 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 3SEC | Lazarus KrikorianSvp & Chief Accounting Officer | Sell Plan | 98614,197 held (−6%) | $330.96 | $326K | +3.6% | — |
| Oct 5SEC | Lazarus KrikorianSvp & Chief Accounting Officer | Sell Plan | 98615,183 held (−6%) | $303.18 | $299K | +13.1% | — |
| Sep 17SEC | Lon R. GreenbergDirector | Sell | 1,28017,128 held (−7%) | $321.30 | $411K | +6.8% | — |
| Sep 2SEC | Lazarus KrikorianSvp & Chief Accounting Officer | Sell Plan | 98516,169 held (−6%) | $325.97 | $321K | +5.2% | — |
| Aug 25SEC | Elizabeth S. CampbellPresident | Sell | 11,30019,455 held (−37%) | $324.12 | $3.7M | +5.8% | — |
| Jun 24SEC | Lauren M. TylerDirectorFirst buy | Buy | 5504,359 held (+14%) | $270.23 | $149K | +26.9% | — |
| Jun 22SEC | Dermot Mark DurcanDirectorFirst buy in 2 yrsPast buys 2/3 beat S&P | Buy | 4,00031,767 held (+14%) | $274.19 | $1.1M | +25.1% | 75 |
| May 28SEC | Dermot Mark DurcanDirectorPast buys 2/3 beat S&P | Buy | 4,00027,767 held (+17%) | $266.26 | $1.1M | +28.8% | 75 |
| Feb 24SEC | Robert P. MauchCEO, President | Sell Plan | 3,76265,393 held (−5%) | $358.94 | $1.4M | -4.4% | — |
| Feb 20SEC | Robert P. MauchCEO, President | Sell Plan | 1,33365,393 held (−2%) | $359.46 | $479K | -4.6% | — |
| Jan 22SEC | Robert P. MauchCEO, President | Sell Plan | 5,09666,726 held (−7%) | $354.73 | $1.8M | -3.3% | — |
| Dec 22SEC | Robert P. MauchCEO, President | Sell Plan | 5,09668,059 held (−7%) | $343.45 | $1.8M | -0.1% | — |
| Dec 22SEC | Elizabeth S. CampbellPresident | Sell | 3,35123,891 held (−12%) | $342.10 | $1.1M | +0.3% | — |
| Dec 22SEC | Silvana BattagliaPresident | Sell | 1,67718,796 held (−8%) | $345.00 | $579K | -0.6% | — |
| Dec 19SEC | Lazarus KrikorianSvp & Chief Accounting Officer | Sell | 4,03117,154 held (−19%) | $343.24 | $1.4M | -0.1% | — |
| Nov 19SEC | Robert P. MauchCEO, President | Sell Plan | 5,09665,746 held (−7%) | $366.64 | $1.9M | -6.4% | — |
| Oct 21SEC | Robert P. MauchCEO, President | Sell Plan | 5,09737,940 held (−12%) | $326.80 | $1.7M | +5.0% | — |
| Oct 3SEC | Elizabeth S. CampbellPresident | Sell Plan | 1,88612,824 held (−13%) | $313.28 | $591K | +9.5% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for COR's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with COR in the Research Lab
Pre-set to COR's latest insider buy of $10K or more (Jun 24, 2026: Dermot Mark Durcan, Lauren M. Tyler, $1.2M). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Cencora insider trading at a glance (Nov 20, 2026): in the past 12 months, 2 insiders bought $2.3M and 5 sold $13.5M of COR stock on the open market; P/E 40.9 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
COR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $625K | 2 |
| Q3 2026 | — | 0 | $4.4M | 3 |
| Q2 2026 | $2.3M | 3 | — | 0 |
| Q1 2026 | — | 0 | $3.6M | 3 |
| Q4 2025 | — | 0 | $9.0M | 7 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 2 Cencora insiders reported open-market purchases totaling $2.3M, while 5 insiders reported sales totaling $13.5M. Among insiders with enough purchase history to measure, Dermot Mark Durcan (Director) has the highest Insider Score at 75. 10 of 15 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
COR earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 4, 2026 | +0.1% | Sold $326K | -0.2%S&P -2.8% | pending |
| Oct 21, 2026 | +8.8% | Sold $299K | -1.4%S&P -0.7% | pending |
| Aug 5, 2026 | +0.8% | None | +6.1%S&P -0.4% | +2.0% |
| May 6, 2026 | -5.3% | None | -16.4%S&P +1.1% | +7.8% |
| Feb 4, 2026 | +1.9% | Sold $1.8M | -2.7%S&P -1.7% | +2.0% |
| Nov 5, 2025 | +5.2% | Sold $1.7M | +4.6%S&P -0.7% | -5.6% |
| Aug 6, 2025 | -0.1% | None | -4.8%S&P +0.7% | +5.3% |
| May 7, 2025 | +3.4% | None | -2.4%S&P +1.1% | +2.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
COR short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded COR
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +10.3% |
What happened after COR insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Jun 24, 2026 | Lauren M. TylerDirector | $149K | +1.4%-0.3% vs S&P | +8.9%+8.2% vs S&P | +10.7%+5.0% vs S&P |
| Jun 22, 2026 | Dermot Mark DurcanDirector | $1.1M | +3.8%+4.3% vs S&P | +10.8%+10.4% vs S&P | +16.9%+12.7% vs S&P |
| May 28, 2026 | Dermot Mark DurcanDirector | $1.1M | +1.0%+0.6% vs S&P | +5.2%+6.8% vs S&P | +22.7%+20.9% vs S&P |
Insiders at Cencora
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Robert P. MauchCEO, President | — | $8.9M | Nov 13, 2026 | — | — |
| Dermot Mark DurcanDirector | $2.2M | — | Jun 22, 2026 | 2 of 3 | 75 |
| Elizabeth S. CampbellPresident | — | $5.4M | Nov 13, 2026 | — | — |
| Lazarus KrikorianSvp & Chief Accounting Officer | — | $2.3M | Nov 13, 2026 | — | — |
| Silvana BattagliaPresident | — | $579K | Jul 7, 2026 | 1 of 1 | — |
| Lauren M. TylerDirector | $149K | — | Nov 3, 2026 | 1 of 1 | — |
| Lon R. GreenbergDirector | — | $411K | Sep 17, 2026 | — | — |
| Pawan VermaEvp, Chief Data & Info Officer | — | — | Nov 13, 2026 | — | — |
| Dennis M. NallyDirector | — | — | Nov 3, 2026 | — | — |
| Ellen CooperDirector | — | — | Nov 3, 2026 | — | — |
| Robert E. SanchezDirector | — | — | Oct 5, 2026 | — | — |
| James F. ClearyCFO | — | — | Mar 13, 2026 | — | — |
| Lori RyerkerkDirector | — | — | Mar 9, 2026 | — | — |
| Lorence H. KimDirector | — | — | Mar 9, 2026 | — | — |
| Frank ClyburnDirector | — | — | Mar 9, 2026 | — | — |
| Redonda MillerDirector | — | — | Mar 9, 2026 | — | — |
| Werner BaumannDirector | — | — | Mar 9, 2026 | — | — |
Board links: companies that share insiders with COR
Directors and executives who filed Form 4s for COR and another company in the last 12 months.
- CNCCentene Lauren M. Tyler Director here · Director at CNC · latest filing Nov 3, 2026
- ETNEaton Lori Ryerkerk Director here · Director at ETN · latest filing May 8, 2026
- MSMorgan Stanley Dennis M. Nally Director here · Director at MS · latest filing Nov 3, 2026
- RRyder System Robert E. Sanchez Director here · Chair at R · latest filing Oct 28, 2026
- RVMDRevolution Medicines Lorence H. Kim Director here · Director at RVMD · latest filing Sep 10, 2026
- TXNTexas Instruments Robert E. Sanchez Director here · Director at TXN · latest filing Oct 29, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
COR stock: common questions
Are Cencora insiders buying COR stock?
In the past 12 months, 2 insiders reported open-market purchases of COR worth $2.3M. The latest was Director Lauren M Tyler bought $149K of COR at $270.23 — first open-market purchase in our records.
Are Cencora insiders selling COR stock?
5 insiders reported sales worth $13.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is COR's P/E ratio?
COR trades at about 40.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is COR's 52-week range?
Over the past year COR has traded between $251.67 and $372.53. It last closed at $343.02 on Nov 20, 2026.